Date : Since 14/04/2020
Place : Montigny le BretonneuxBioreagents
Thanks to the newly signed distribution agreement between Cayman Chemical Company and GenScript Biotech Corporation, Bertin is now offering qRT-PCR kits for SARS-CoV-2 nucleic acid detection and ELISA kits for the detection of Spike S1-RBD IgG and IgM. Those products will help research community to tackle the challenge on COVID-19 therapeutics and diagnostics.
qRT-PCR detection assays
The qRT-PCR detection assays are based on GenBank Sequence NC_045512.2. The primers and probes target ORF1ab gene, N gene, or RdRP gene and E gene in the SARS-CoV-2 genome. These assays use a 1 step protocol and have successfully detected SARS-CoV-2 in positive control samples. While additional testing is ongoing, these assays should be considered for Research Use Only (RUO)—not for diagnoses.
Available qRT-PCR detection assays include:
Looking at antibodies developed by an organism after an infection is allows to study its immunity. The 2 ELISA kits below can be used to evaluate IgG and IgM targeting SARS-CoV-2 Spike S1-RBD in serum/plasma samples. These kits are RUO and are useful in SARS-CoV-2 research, however, results obtained from these ELISAs are not to be used as a clinical diagnostic test.
Available ELISAs include: